Bioantibody Biotechnology

Bioantibody Biotechnology Co., Ltd, a Nanjing-based in vitro diagnostics (IVD) and biologic company, has reportedly raised close to RMB 100 million (USD 14.8 million) in a Series A financing round. The funding was led by FangFund, with contributions from Nanjing New Industry Investment Capital, Guoqian Venture Investment Management, and Bondshine…